Idexx Laboratories Other segment revenue — Total Revenue increased by 3.6% to $4.40M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 5.5%, from $4.17M to $4.40M. Over 2 years (FY 2021 to FY 2023), Other segment revenue — Total Revenue shows a downward trend with a -33.9% CAGR.
An increase suggests successful diversification or the scaling of emerging business lines, while a decrease may indicate a strategic divestiture or declining interest in non-core offerings.
This metric represents the total revenue generated by business activities that do not fall into the company's primary re...
Peers often report this as 'Other' or 'Corporate/Other' revenue, which typically represents a small percentage of total consolidated sales.
idxx_segment_other_segment_revenue_total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.83M | $10.66M | $10.89M | $8.12M | $7.38M | $7.38M | $7.33M | $4.83M | $4.04M | $4.17M | $5.76M | $3.53M | $4.25M | $4.40M |
| QoQ Change | — | +8.4% | +2.2% | -25.4% | -9.2% | +0.1% | -0.7% | -34.1% | -16.3% | +3.3% | +38.0% | -38.6% | +20.2% | +3.6% |
| YoY Change | — | — | — | — | -25.0% | -30.8% | -32.7% | -40.6% | -45.2% | -43.5% | -21.4% | -26.8% | +5.2% | +5.5% |